Background illustration for clinical trials search

Paid Clinical Trials Hershey

Discover 532 paid clinical trials in Hershey, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Evaluation of a Peer Recovery Support Program Adapted to Target Retention in Clinic-based Medication for Opioid Use Disorder Treatment

for
Opioid Use Disorder
Location: Danville PA
Sponsor: Geisinger Clinic

Sex: All

Age: 18 - 70+

Code: NCT07197801

Recruiting

Clinical and Radiographic Success of MTA vs Biodentine

for
Indirect Pulp Cap, Pulpotomy
Location: Danville PA
Sponsor: Geisinger Clinic

Sex: All

Age: 2 - 12

Code: NCT04863222

Recruiting

Biomechanical Footwear as a Non-invasive Alternative and Supplement to Total Knee Replacement

for
Osteoarthritis, Knee
Location: Danville PA, Wilkes-Barre PA
Sponsor: Geisinger Clinic

Sex: All

Age: 45 - 70+

Code: NCT04732962

Recruiting

PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

for
Type2Diabetes, ASCVD
Location: Danville PA, Baltimore MD, Philadelphia PA, Manassas VA,
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 40 - 70+

Code: NCT05390892

Recruiting

Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial

for
Lymphoma, Malignant Solid Neoplasm
Location: Danville PA, Newark DE, Wilkes-Barre PA, Scranton PA,
Sponsor: University of Rochester

Sex: All

Age: 18+

Code: NCT05006482

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

for
Advanced Colorectal Carcinoma,
Location: Danville PA, Lewisburg PA, Elkton MD, Newark DE,
Sponsor: University of Rochester

Sex: All

Age: 18+

Code: NCT06073431

Recruiting

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

for
Anaplastic Large Cell Lymphoma, ALK-Negative,
Location: Danville PA, Elkton MD, Newark DE, Chadds Ford PA,
Sponsor: Eastern Cooperative Oncology Group

Sex: All

Age: 18 - 70+

Code: NCT06724237

Phase 3, Recruiting

Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

for
Hidradenitis Suppurativa (HS)
Location: Danville PA, Baltimore MD, Farmington CT, Toronto,
Sponsor: Incyte Corporation

Sex: All

Age: 12 - 17

Code: NCT07213973

Phase 2, Recruiting

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia
Location: Danville PA, Wilkes-Barre PA, Philadelphia PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06672146

Phase 2, Recruiting

Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial

for
Advanced Hepatocellular Carcinoma,
Location: Danville PA, Lewisburg PA, Newark DE, Chadds Ford PA,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT07166406

Phase 3, Recruiting

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD),
Location: Danville PA, Jupiter FL, Miami FL, Metairie LA,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07527910

Phase 2, Recruiting

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia
Location: Danville PA, Newark DE, Wilkes-Barre PA,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 65+

Code: NCT07321652

Phase 3, Recruiting

Informing Low-acuity Emergency Department Patients of Non-emergent Resources (2)

for
Emergency Service, Hospital, Behavior Change Interventions
Location: Danville PA
Sponsor: Geisinger Clinic

Sex: All

Age: 18+

Code: NCT07185828

Recruiting

Endoscopic Ultrasound Shear Wave Elastography Study

for
MASLD, MASH, Fibrosis, Liver, Chronic Liver Disease
Location: Danville PA, Boston MA, Newport Beach CA
Sponsor: Olympus Corporation of the Americas

Sex: All

Age: 18+

Code: NCT06592820

Recruiting

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

for
Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia
Location: Danville PA, Wilmington DE, Philadelphia PA,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 25

Code: NCT07022678

Phase 3, Recruiting

Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)

for
Core Binding Factor Acute Myeloid Leukemia
Location: Danville PA, Wilkes-Barre PA, The Bronx NY, Syracuse NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT06917911

Phase 2, Recruiting

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

for
Pancreatic Neoplasm
Location: Danville PA, Hazleton PA, Allentown PA, Paoli PA,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 50 - 70+

Code: NCT04239573

Recruiting

CMSL Ambulatory Sensitive Condition Nudge Study 2

for
Behavioral Intervention, Emergency Department Visits,
Location: Danville PA
Sponsor: Geisinger Clinic

Sex: All

Age: 30+

Code: NCT07028398

Recruiting

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

for
Recurrent Non-Muscle Invasive Bladder Carcinoma,
Location: Danville PA, Lewisburg PA, Baltimore MD, Frederick MD,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT07000084

Phase 3, Recruiting

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

for
Recurrent Langerhans Cell Histiocytosis,
Location: Danville PA, Baltimore MD, Wilmington DE,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 22

Code: NCT05828069

Phase 2, Recruiting